Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Completed 5Recruiting 3Active not recruiting 3

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 5Carcinoma in Situ 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Mastectomy, Subcutaneous × Breast × Clear all
NCT02311959 2026-04-14

MAPAM-01

Institut Claudius Regaud

Phase 3 Completed
450 enrolled
Breast

Breast Neoplasms, Carcinoma in Situ

NCT02891759 2023-05-06

Compare Outcomes Between Two Acellular Dermal Matrices

Washington University School of Medicine

Phase 2 Completed
320 enrolled
Breast

Breast Neoplasms

NCT01002014 2022-04-21

Nipple Sparing Mastectomy - Cosmetic Outcomes

Wake Forest University Health Sciences

Phase NA Completed
75 enrolled
Breast

Breast Neoplasms

NCT04640454 2020-11-23

Assessment of Nipple Sparing Mastectomy as a Treatment Option for Breast Cancer

Alexandria University

Completed
35 enrolled
Breast

Breast Neoplasms

NCT02061527 2018-04-24

Breast Reconstruction With Acellular Dermal Matrix in the Setting of Breast Cancer Treatment

Karolinska University Hospital

Phase NA Completed
135 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡